Otonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

Back to Jobs

Topline data for OTO -104 Phase 3 trials in Ménière’s disease expected in 2H2017 Implemented changes to commercial organization to improve OTIPRIO ® sales performance Company to host conference call and webcast today at 4:30 p.m. EST SAN DIEGO , March 02, 2017 (GLOBE NEWSWIRE) — Otonomy ,

Apply Now